1 Product identity

CBD+13

Name: CBD+13
Brand: T-Relief

T-Relief

Other Combinations Tablet or Pill 21 ingredients 2 caution DSLD #208766

Net contents: 30 Tablet(s)

Target: Adults and Children 4 years and above

DSLD entry: 2019-12-22

2 Ingredients (21)

IngredientGroupSafety

CannabidiolCannabidiol—

Proprietary BlendProprietary Blend (Herb/Botanical)—

Amica montanaArnica—

Aconitum napellusAconite—

Baptisia tinctoriaWild Indigo—

BelladonnaBelladonnaBanned

Bellis perennisWild Daisy—

Calendula officinalisCalendula—

ChamomillaGerman Chamomile —

EchinaceaEchinacea (unspecified)Conditionally Safe

Hamamelis virginianaWitch Hazel—

Hypericum perforatumSt. John's WortUse with Caution

MillefoliumYarrow—

Ruta graveolensRue—

Symphytum officinaleComfrey—

LactoseLactose—

organic Berry flavor BlendFlavor—

MCT Oil powderMedium chain triglycerides (MCT)Generally Safe

Citric AcidCitric Acid—

Magnesium StearateMagnesium StearateGenerally Safe

organic SteviaStevia—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

3 Safety cross-reference

Belladonna — Banned

⚠ Contains atropine, scopolamine, hyoscyamine

⚠ Anticholinergic toxicity: tachycardia, hallucinations, seizures, death

NAC — Conditionally Safe

⚠ GI upset

⚠ Rare bronchospasm

St. John's Wort — Use with Caution

⚠ MAJOR CYP3A4 INDUCER — interacts with >50% of drugs

⚠ Serotonin syndrome with SSRIs

MCT Oil — Generally Safe

⚠ GI distress initially

Magnesium — Generally Safe

⚠ Diarrhea (especially oxide)

⚠ Accumulates in renal impairment

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID208766

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2019-12-22

6 More from T-Relief

View T-Relief Safety Scorecard → 1 products

7 Cite this page

Vancouver

Pkhakadze G. CBD+13 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/products/cbd13-208766/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG